SFP
PDSB icon

Sandbox Financial Partners’s PDS Biotechnology PDSB Stock Holding History

Sandbox Financial Partners’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-12,666
Closed -$16.8K – 133
2025
Q2 		$16.8K Hold
12,666
– – 0.01% 122
2025
Q1 		$15.1K Buy
+12,666
New +$18K 0.01% 109

Other funds holding PDSB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sandbox Financial Partners's PDSB Position: Q3 2025 in Review

Sandbox Financial Partners sold out of PDS Biotechnology (PDSB) in Q3 2025, closing a stake of 12,666 shares — an estimated $16.8K sold.

Sandbox Financial Partners first reported a position in PDSB in Q1 2025 and held it in 2 quarters. The position peaked at $16.8K in Q2 2025. 47 funds tracked by Wall St. Rank hold PDSB as of Q3 2025.

  • Sandbox Financial Partners reported no remaining PDS Biotechnology position as of Q3 2025 after selling out during the quarter.
  • Sandbox Financial Partners sold 12,666 PDS Biotechnology shares in Q3 2025, an estimated $16.8K.
  • Sandbox Financial Partners first reported a position in PDS Biotechnology in Q1 2025 and held it in 2 quarters.
  • Sandbox Financial Partners's PDS Biotechnology position peaked at $16.8K in Q2 2025.
  • 47 funds tracked by Wall St. Rank held PDS Biotechnology as of Q3 2025.

Based on Sandbox Financial Partners's 13F filing for Q3 2025, filed 17 Oct 2025.